Skip to Main Content

Paper Details

Targeting CD157 in AML using a novel, Fc-engineered antibody construct.
Oncotarget
30
2017
Author NameAffiliation
Thomas K??hnke
Thomas K??hnkeClinical Cooperation Group Immunotherapy at The Helmholtz Institute Munich
Thomas K??hnkeLudwig-Maximilians-University Munich
  • 1 - 3

Datasets

Release 1.2